Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

Clinical trial NCT04460235 · RECRUITING

Trial details

NCT number: NCT04460235
Sponsor: Poitiers University Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccine Streptococcus Pneumoniae Lymphoma, Non-Hodgkin

Start date: 2021-09-07
Primary completion: 2028-06-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.